Tipoffs for Maine (New England)
Cornell: Brooks School Dean Colleen Barry joins the Sandy Hook Promise Board of Directors
ITHACA, New York, Aug. 30 (TNSper) -- Cornell University issued the following news:
By Jim Hanchett
Colleen L. Barry, Inaugural Dean of the Cornell Jeb E. Brooks School of Public Policy, has joined the board of directors for Sandy Hook Promise, one of the nation's leading gun violence prevention and school safety organizations.
Barry is a nationally and internationally recognized research scholar, educator, and leader in health policy and policy communication. Since 2013, she has led the bi-a
more
Mass. Conservation & Recreation Dept.: Baker-Polito Administration Announces Greening Gateway Cities Program Partnership, Implementation Grants
HOLYOKE, Massachusetts, Aug. 30 -- The Massachusetts Department of Conservation and Recreation issued the following news release on Aug. 29, 2022:
Baker-Polito Administration today announced $825,703 in grants to support tree plantings in Gateway Cities across the Commonwealth. Five Massachusetts municipalities and two non-profit organizations will receive awards totaling $629,684 through the Greening the Gateway Cities (GGCP) Implementation Grant Program and an additional eleven projects are r
more
Results of Phase 3 Ublituximab Trials Published, Showing Benefit in Relapsing MS
NEW YORK, Aug. 30 (TNSres) -- The National Multiple Sclerosis Society issued the following news:
Ublituximab (an experimental therapy being developed by TG Therapeutics) reduced relapses and disease activity on MRI scans significantly more than Aubagio(R) (teriflunomide, Sanofi Genzyme) in two phase 3 clinical trials. These results, originally reported at a medical meeting in 2021, have now been peer-reviewed and published in The New England Journal of Medicine. According to an August 25 press
more
University of Glasgow: New treatment significantly lowers the risk of cardiovascular death in patients with heart failure
GLASGOW, Scotland, Aug. 30 (TNSjou) -- The University of Glasgow issued the following news:
A medication, commonly used for the treatment of type 2 diabetes, has been found to significantly lower the risk of cardiovascular death in patients with heart failure. A team of international researchers also found that the same drug was able to reduce worsening heart failure.
Two linked studies, published in the New England Journal of Medicine and Nature Medicine, and delivered at the European Society
more
